Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.
Robert Lavieri, Sarah A Scott, Jana A Lewis, Paige E Selvy, Michelle D Armstrong, H Alex Brown, Craig W Lindsley
Index: Bioorg. Med. Chem. Lett. 19 , 2240-3, (2009)
Full Text: HTML
Abstract
This Letter describes the synthesis and structure-activity relationships (SAR) of isoform-selective PLD inhibitors. By virtue of the installation of a 1,3,8-triazaspiro[4,5]decan-4-one privileged structure, PLD inhibitors with nanomolar potency and an unprecedented 40-fold selectivity for PLD2 over PLD1 were developed. Interestingly, SAR for this diverged from our earlier efforts, and dual PLD1/2 inhibitors were also discovered within this series.
Related Compounds
Related Articles:
1987-01-28
[Eur. J. Pharmacol. 134(1) , 113-6, (1987)]
2007-08-01
[Drug Metab. Dispos. 35(8) , 1387-92, (2007)]
2008-09-15
[Bioorg. Med. Chem. 16 , 8737-44, (2008)]
Determination of trace atmospheric isocyanate concentrations by reversed-phase high-performance liquid chromatography using 1-(2-pyridyl) piperazine reagent. Goldberg PA, et al.
[J. Chromatogr. A. 212(1) , 93-104, (1981)]
Determination of atmospheric isocyanate concentrations by high-performance thin-layer chromatography using 1-(2-pyridyl) piperazine reagent. Ellwood PA, et al.
[Analyst 106(1258) , 85-93, (1981)]